Internal Medicine, Medical Oncology · Houston, TX
NPI
1447355003
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
406 services
Medicare patients, 2024
157
Average age 69
Drug cost, 2024
$1.1M
311 prescriptions
Company payments, 2025
$4,813
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vincente Valero was code 99215 (office e&m - established), 191 times for 85 patients. In total Vincente Valero billed 406 services in 12 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-07-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 191 | 85 | $104.80 | $20K |
| 99214 Office E&M - Established | Facility | 124 | 84 | $67.62 | $8,385 |
| 99214 Office E&M - Established | Office | 29 | 16 | $96.67 | $2,803 |
| 99215 Office E&M - Established | Office | 24 | 15 | $112.90 | $2,710 |
| 99205 Office E&M - New | Facility | 11 | 11 | $132.12 | $1,453 |
By year: 2022 $36K for 416 services; 2023 $33K for 385 services; 2024 $38K for 406 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vincente Valero prescribed most often to Medicare patients was Anastrozole, with 85 prescriptions and refills. In total Vincente Valero wrote 311 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 85 | 233 | 32 | $1,698 |
| Letrozole Generic | 51 | 148 | 21 | $1,826 |
| Kisqali Ribociclib Succinate | 24 | 24 | Under 11 | $390K |
| Tamoxifen Citrate Generic | 21 | 57 | Under 11 | $607 |
| Tukysa Tucatinib | 14 | 14 | Under 11 | $348K |
| Ondansetron Hcl Generic | 13 | 13 | Under 11 | $60.24 |
| Gabapentin Generic | 13 | 14 | Under 11 | $175 |
| Prochlorperazine Maleate Generic | 11 | 11 | Under 11 | $109 |
Brand drugs: 66 claims; generic drugs: 245 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vincente Valero $4,813 ($4,813 in general payments such as food, travel and fees) from 8 companies. The largest payer was Gilead Sciences, Inc. with $2,805.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.